Hormone replacement therapy and breast cancer: estimate of risk: Education debate

Coombs, Nathan J., Taylor, Richard, Wilcken, Nicholas and Boyages, John (2005) Hormone replacement therapy and breast cancer: estimate of risk: Education debate. British Medical Journal, 331 7512: 347-349. doi:10.1136/bmj.331.7512.347

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ_PV_55646.pdf Publisher version application/pdf 256.02KB 123

Author Coombs, Nathan J.
Taylor, Richard
Wilcken, Nicholas
Boyages, John
Title Hormone replacement therapy and breast cancer: estimate of risk: Education debate
Journal name British Medical Journal
ISSN 0959-8146
Publication date 2005-08-06
Sub-type Article (original research)
DOI 10.1136/bmj.331.7512.347
Open Access Status File (Author Post-print)
Volume 331
Issue 7512
Start page 347
End page 349
Total pages 3
Place of publication London, United Kingdom
Publisher BMJ
Language eng
Subject 320000 Medical and Health Sciences
11 Medical and Health Sciences
1112 Oncology and Carcinogenesis
Abstract The risk of breast cancer arises from a combination of genetic susceptibility and environmental factors. Recent studies show that type and duration of use of hormone replacement therapy affect a women's risk of developing breast cancer.1-7 The women's health initiative trial was stopped early because of excess adverse cardiovascular events and invasive breast cancer with oestrogen and progestogen.6 The publicity increased public awareness of the risks of hormone replacement therapy, and this was heightened by the publication of the million women study.2 However, the recently published oestrogen only arm of the women's health initiative trial suggests that this formulation may reduce the risk of breast cancer.8 To help make sense of the often confusing information,9 women and clinicians need individual rather than population risk data. We have produced estimates that can be used to calculate individual risk for women living up to the age of 79 and suggest the risk
Keyword Medicine, General & Internal
Healthy Postmenopausal Women
Randomized Controlled-trial
Estrogen Plus Progestin
Q-Index Code C1
Institutional Status Non-UQ
Additional Notes Originally published as: Hormone replacement therapy and breast cancer: estimate of risk Nathan J Coombs, Richard Taylor, Nicholas Wilcken, John Boyages BMJ 2005;331:347-349, doi:10.1136/bmj.331.7512.347 Copyright 2005 BMJ Publishing. All rights reserved. Reproduced with permission.

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
School of Public Health Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 7 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 13 Aug 2007, 15:26:27 EST